Her Doctor Used to File Four Prior Authorizations for One Cancer Case. Aetna Medicaid Is Folding Them Together in 8 States

A lymphoma patient on Medicaid can face four separate insurance permission slips before her first treatment begins, and every one of those gates is a chance for her care to stall. Aetna is rethinking that process in eight states, but…

Published October 6, 2026, 6:03am ET · 4 min read

The Full Benefits Desk desk. Editor: Gerelyn Terzo.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A male doctor in a white lab coat and blue tie stands at the bedside of a female patient, who is lying in a hospital bed wearing a patterned blue and white headscarf and a hospital gown. The doctor holds a gray tablet and looks down at it, while the patient looks at him with a serious expression. An IV drip bag is visible in the upper left background.
A doctor discusses treatment options with a patient, reflecting the critical conversations that Aetna Medicaid aims to streamline with its new prior authorization policies for cancer care. © Ridofranz / iStock via Getty Images

A grandmother on an Aetna Medicaid plan diagnosed with lymphoma faces a treatment plan that builds fast: chemotherapy or immunotherapy, radiation, and CT or MRI scans. Her oncology office could expect to file four separate prior authorizations to get that plan approved, which is Aetna’s own average for a member needing cancer treatment.

Aetna is cutting that stack down to one. CVS Health (NYSE:CVS | CVS Price Prediction) says its Aetna unit now bundles those approvals into a single request for eligible Medicaid members in Oklahoma, Illinois, Maryland, New Jersey, Virginia, Florida, Kentucky and West Virginia. The expansion covers all cancer types and took effect September 1.

How Aetna’s Oncology Bundle Turns 4 Requests Into 1

Prior authorization is the insurer’s permission slip. Before the plan pays for an expensive drug, scan or procedure, the doctor’s office sends clinical records and waits for approval. Cancer care generates enough of these slips to cover a waiting room because treatment rarely involves just one service.

Aetna’s bundle combines medical oncology, including chemotherapy and immunotherapy where appropriate, and/or radiation oncology services with associated high-tech imaging needs, such as MRI or CT scans, into one request submitted through a single portal. That portal is Eviti. The eight-state eligibility applies to providers that utilize the Eviti portal to submit prior authorizations.

Aetna tested the idea on a narrower rollout first. In that phase, almost 25% of eligible members received a bundled authorization, according to the company’s September 17, 2026 announcement.

“By approving a broader set of treatments and related services upfront, we’re removing barriers that can delay care,” said Katerina Guerraz, Aetna’s chief operating officer and president of Medicaid, in the announcement. “Oncologists have the flexibility to make care decisions as treatment plans evolve.”

Fewer Approval Cycles Mean Fewer Chances for Treatment to Stall

Every separate authorization creates a gate. The office files, waits, answers follow-up questions and sometimes appeals. A patient who just finished a chemo cycle can face another wait while the radiation request moves through approval.

Bundling those services can reduce paperwork and the chances that treatment stalls while the office goes back for another authorization. Fewer cycles mean fewer fax-machine standoffs between clinic and plan reviewer.

Doctors feel the drag, too. In Aetna’s latest provider survey, 74% of providers called administrative burden the top challenge facing clinical staff, and 31% named prior authorization management as the single largest cause. 80% expect to save more than 30 minutes a day through tools like bundles.

Medicaid is the joint federal-state program serving eligible people with limited income, including millions enrolled through state Medicaid plans. For now, the expanded bundle applies to eligible Aetna Medicaid members in the eight participating states whose providers submit through Eviti. Aetna expects to extend eligibility to Medicare and commercial members in the first half of 2027.

Geography matters as well. Each state runs its own Medicaid program, so covered drug lists, imaging rules and provider networks shift from state to state. Aetna Medicaid members outside the eight listed states, or whose oncologist doesn’t file through Eviti, fall outside the current rollout.

Coverage, Network and Medical-Necessity Rules Still Apply

The bundle speeds up the paperwork and leaves the rulebook intact. It does not override covered-benefit rules, network requirements or medical-necessity standards.

In practice, a drug the state’s Medicaid plan bars stays bars. An out-of-network radiation center stays out of network. A reviewer still checks that the proposed treatment fits the clinical evidence before the approval comes through.

Families who ask a few direct questions early tend to avoid surprises later. The first set goes to the plan and the oncology practice:

  • Does this practice submit through Eviti and use the bundled process for Medicaid members?
  • Does this patient’s plan qualify for the bundle in her state?

The second set covers each piece of the treatment plan:

  • Is every drug on the plan’s covered list?
  • Are the imaging center and the radiation facility in network, along with the oncologist?
  • If the treatment plan changes midway, does the existing bundle cover the new service, or does the office need a fresh request?

Adult children helping a parent through treatment can handle these calls. Reaching out to the plan’s member services line before the first infusion beats discovering a coverage problem three weeks in.

One authorization removes the repeat gates that slow cancer care, while coverage, network and medical-necessity rules still mark the boundaries. Families who confirm those details at the first appointment should receive the full benefit of the faster process.

Contact [email protected] for any questions or corrections.

Gerelyn Terzo

Gerelyn Terzo is the author of dividend investing handbook "Dividend Investing Strategies: How to Have Your Cake & Eat It Too." A veteran financial journalist, she covers agri-finance for outlets like Global AgInvesting and the broader stock market and personal finance for 24/7 Wall Street. She began at CNBC and later helped launch Fox Business in New York. Gerelyn currently resides in Woodland Park, Colorado and dabbles in nature photography as a hobby.

All articles →